ASMB
NASDAQ · Biotechnology
Assembly Biosciences Inc
$24.44
+0.29 (+1.20%)
Open$24.60
Previous Close$24.15
Day High$25.93
Day Low$24.22
52W High$39.71
52W Low$16.50
Volume—
Avg Volume188.1K
Market Cap484.33M
P/E Ratio—
EPS$-1.29
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
-55.3% upside
Current
$24.44
$24.44
Target
$10.92
$10.92
$9.01
$10.92 avg
$17.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 136.05M | 44.93M | 300.07M |
| Net Income | -11,519,798 | -56,963,075 | 8.49M |
| Profit Margin | -8.5% | -133.8% | 2.8% |
| EBITDA | -22,558,639 | -67,781,254 | 15.38M |
| Free Cash Flow | — | — | 12.77M |
| Rev Growth | — | +65.8% | +3.4% |
| Debt/Equity | — | — | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |